
David Fried
Physician · Rhode Island Hospital/Brown University Health
Credentials: · · · ·
History
Research
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
New England Journal of Medicine · 2022 · 363 citations
International Wound Journal · 2014 · 195 citations
Vaccine · 2013 · 15 citations
- DV
2 papers

2 papers
- JN
2 papers
- KS
2 papers
- LL
2 papers
- MR
2 papers
- RJ
2 papers

1 paper
Clinical trials
- 2012–2019
Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)
Principal investigator · Completed · Phase 2
Pluristem Ltd.
- 2007
Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis
Principal investigator · Completed · Phase 2
NanoBio Corporation
- 2007
Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.
Principal investigator · Completed · Phase 2
BioCryst Pharmaceuticals
- 2023–2026
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Site PI · Recruiting · Phase 2
Housey Healthcare ULC

